AT-18 SURVIVAL ANALYSIS OF PATIENTS WITH A PFS EVENT WHO DID NOT RECEIVE POST-PROGRESSION THERAPY IN AVAGLIO (BEVACIZUMAB [BEV] PLUS RADIOTHERAPY [RT] AND TEMOZOLOMIDE [TMZ] FOR NEWLY DIAGNOSED GLIOBLASTOMA [GBM])

BACKGROUND: Many patients with GBM only receive one line of therapy. GBM patients who cannot receive post-PD therapy are not easily identifiable at diagnosis and may represent up to 50% of patients (Graus, Neuro Oncol 2013; Chen, Asia Pac J Clin Oncol 2013). Since post-study treatment may confound O...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cloughesy, Tim, Wick, Wolfgang, Mason, Warren, Henriksson, Roger, Saran, Frank, Nishikawa, Ryo, Carpentier, Antoine F., Hoang-Xuan, Khe, Kavan, Petr, Cernea, Dana, Brandes, Alba A., Revil, Cedric, Abrey, Lauren, Chinot, Olivier L.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2014
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4217795/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou237.18
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados